www.fdanews.com/articles/123961-acorda-obtains-fda-nod-for-oral-drug-to-improve-walking-in-ms-patients
Acorda Obtains FDA Nod for Oral Drug to Improve Walking in MS Patients
January 25, 2010
Acorda Therapeutics received approval to market Ampyra in the
U.S. to improve walking in patients with multiple sclerosis.
GEN
GEN